Sepsis induces extensive lymphocyte apoptosis, a process which may be benef
icial to host survival by down-regulating the inflammatory response or, alt
ernatively, harmful by impairing host defenses. To determine the beneficial
vs. adverse effects of lymphocyte apoptosis in sepsis, we blocked lymphocy
te apoptosis either by N-benzyloxycarbonyl-Val-Ala-Asp(O-methyl) fluorometh
yl ketone (z-VAD). a broad-spectrum caspase inhibitor, or by use of Bcl-2 I
g transgenic mice that selectively overexpress the antiapoptotic protein Bc
l-2 in a lymphoid pattern. Both z-VAD and Bcl-2 prevented lymphocyte apopto
sis and resulted in a marked improvement in survival. z-VAD did not decreas
e lymphocyte tumor necrosis factor-alpha production. Considered together, t
hese two studies employing different methods of blocking lymphocyte apoptos
is provide compelling evidence that immunodepression resulting from the los
s of lymphocytes is a central pathogenic event in sepsis. and they challeng
e the current paradigm that regards sepsis as a disorder resulting from an
uncontrolled inflammatory response. Caspase inhibitors may represent a trea
tment strategy in this highly lethal disorder.